Platinum nanoparticles–decorated graphene-modified glassy carbon electrode toward the electrochemical determination of ascorbic acid, dopamine, and paracetamol - 21/01/19
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 15 |
| Iconographies | 11 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
In the present study, we report the synthesis and characterization of platinum nanoparticles decorated graphene (GPtNPs) nanocomposite toward the electrochemical determination of ascorbic acid (AA), dopamine (DA), and paracetamol (PCT). GPtNPs demonstrated synergistic catalytic activity with enhanced currents in all of the measurements when compared with graphene-modified glassy carbon electrode (G-GCE) and bare GCE. The nanocomposite exhibited low overpotential for AA oxidation and good peak-to-peak separation of 218.0, 218.0, and 436.0 mV for AA–DA, DA–PCT, and AA–PCT, respectively. Cyclic voltammetry (CV) and chronoamperometry (CA) determination of AA, DA, and PCT showed wide linearity ranges. CV determination of AA exhibited linearity range from 300 μM to 20.89 mM and from 22.02 to 39.87 mM. DA determination using CV exhibited linearity range from 5 to 104 μM and from 114 to 684 μM, whereas CA determination of PCT showed a linearity range from 20 μM to 6.43 mM. Differential pulse voltammetry determinations of AA, DA, and PCT exhibited low detection limits of 300, 5, and 5 μM, respectively.
Le texte complet de cet article est disponible en PDF.Keywords : Platinum nanoparticle–decorated graphene, Ascorbic acid, Dopamine, Paracetamol
Plan
Vol 22 - N° 1
P. 58-72 - janvier 2019 Retour au numéro
Article précédent
- Development and physicochemical characterization of doxorubicin-encapsulated hydroxyapatite–polyvinyl alcohol nanocomposite for repair of osteosarcoma-affected bone tissues
- Saikat Ghosh, Rathnakaram Siva Kumar Raju, Nilanjana Ghosh, Koel Chaudhury, Sampad Ghosh, Indranil Banerjee, Nabakumar Pramanik
- Novel 4-azaandrostenes as prostate cancer cell growth inhibitors: Synthesis, antiproliferative effects, and molecular docking studies
- Vanessa Brito, Adriana O. Santos, Paulo Almeida, Samuel Silvestre
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?